Level | Description | Reference |
---|---|---|
Study | Â | |
 Year of publication | — | — |
 Implementation frameworks used | e.g., RE-AIM [29] or Consolidated Framework for Implementation Research [28] | Nilsen [30] |
 Study design | Qualitative, cross-sectional, cohort, non-randomized pre/post with and without controls, individual and cluster randomized trials, economic evaluations, or other | — |
 Study type | Effectiveness, type 1 hybrid, type 2 hybrid, type 3 hybrid, implementation, or scale-up | Curran et al. [31] |
 Study population | Community, patient, provider, and/or policy-makers | — |
 Implementation outcomes reported | Acceptability, adoption, appropriateness, feasibility, fidelity, cost, penetration, and/or sustainability | Proctor et al. [24] |
 Non-implementation outcomes reported | Outcomes related to stigma, service delivery, and patient health | — |
 Key findings | — | — |
 Reporting of implementation outcomes | — | |
 Included in study objectives? | Whether the implementation outcome(s) were included in the study’s prespecified objectives |  |
 Hypothesis or conceptual model stated? | Whether the implementation outcomes were motivated by a hypothesis or conceptual model |  |
 Methods for outcomes specified? | Whether the methods for measuring the implementation outcomes were included |  |
 Used validated measure(s)? | Whether the measures used were from or based on a validated measure |  |
 Sample size specified? | Whether the implementation outcomes included the sample size of the population assessed |  |
Intervention | Â | |
 Intervention description | — | — |
 WHO Region | Sub-Saharan Africa, East Asia and Pacific, South Asia, Middle East and North Africa, Europe and Central Asia, Latin America and the Caribbean | — |
 Stigmatizing health condition | — | — |
 Type of stigma reduction intervention | Information/education, skill development, counseling or support, contact events, structural, biomedical | Stangl et al. [3] |
 Stigma domain targeted | Driver, facilitator, and/or manifestation | Stangl et al. [3] |
 Type of stigma targeted | Community, experienced, internalized, anticipated, and/or unclear | Turan et al. [40] |
Intervention specification using the TIDieR Checklist | Hoffman et al. [41] | |
 Why | Intervention motivated with a rationale, theory, or goal |  |
 What | Description or link of the intervention’s physical or informational materials |  |
 Who provided | Expertise, background, and any specific training of the person implementing the intervention |  |
 How | Mode of delivery (e.g., face-to-face) |  |
 Where | Type of location of the intervention |  |
 When and how much | Timing, duration, dose, and intensity of the intervention |  |
 Tailoring | Intervention is personalized to participants or groups of participants |  |
 Modifications | Whether the intervention was modified during the course of the study |  |
 How well was fidelity assessed | Methods for assessing fidelity |  |
 Quality of fidelity | If fidelity was assessed, the rating of the fidelity |  |